Literature DB >> 1192566

Chronic one-kidney hypertension in rabbits. I. Treatment with kidney extracts.

L T Skeggs, J R Kahn, M Levine, F E Dorer, K E Lentz.   

Abstract

An investigation into the mechanism that sustains the blood pressure in chronic one-kidney hypertension in rabbits was made using passive and active immunization with hog kidney extracts containing renin and with angiotensin antagonists. Seven hypertensive rabbits were passively immunized for extended periods with antiserum prepared in other rabbits. Antirenin levels were in the range of 1-3 units/ml. Control experiments demonstrated that antirenin concentrations of 1.0 unit/ml or more eliminated more than 99% of the pressor response to renin. There was no lowering of blood pressure that could be attributed to the antibodies. No decrease in blood pressure was observed in 13 experiments in 7 rabbits given the angiotensin II antagonist 1-Sar-8-Ile-angiotensin II; infusion rates of 0.09-87 mug/min kg-1 were used for periods of a few hours up to 3 days. A reduction in blood pressure occurred in 16 of 19 rabbits immunized directly with extracts containing renin with specific activities of 9.6-757 GU/mg. Plasma antirenin titers correlated poorly with reductions in blood pressure. The blood pressure of 22 rabbits given equal amounts of protein without renin was unaffected. It is concluded that the elevation of blood pressure in rabbits with chronic one-kidney hypertension is not dependent on ciculating renin or angiotensin; rather, it results from the presence of renin in an extravascular location or from an unknown pressor substance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192566     DOI: 10.1161/01.res.37.6.715

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  2 in total

1.  Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice.

Authors:  Futoshi Nakagami; Hiroshi Koriyama; Hironori Nakagami; Mariana Kiomy Osako; Munehisa Shimamura; Mariko Kyutoku; Takashi Miyake; Tomohiro Katsuya; Hiromi Rakugi; Ryuichi Morishita
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 2.  Peptide Vaccines for Hypertension and Diabetes Mellitus.

Authors:  Hironori Nakagami; Hiroshi Koriyama; Ryuichi Morishita
Journal:  Vaccines (Basel)       Date:  2014-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.